Orthofix Medical Inc. (OFIX) Q4 2024 Earnings Call Transcript
2025-02-25 13:40:53 ET
Orthofix Medical Inc. (OFIX)
Q4 2024 Earnings Conference Call
February 25, 2025 08:30 am ET
Company Participants
Julie Dewey - Chief Investor Relations and Communications Officer
Massimo Calafiore - President and Chief Executive Officer
Julie Andrews - Chief Financial Officer
Conference Call Participants
Caitlin Cronin - Canaccord Genuity
Mathew Blackman - Stifel
Presentation
Operator
Thank you for standing by. My name is Jeannie and I will be your conference operator today. At this time, I would like to welcome everyone to the Orthofix Q4 2024 Earnings Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. [Operator Instructions]. Thank you.
I would now like to turn the call over to Julie Dewey. Please go ahead.
Julie Dewey
Thank you, operator, and good morning everyone. Welcome to Orthofix's fourth quarter 2024 earnings call. We appreciate you joining us. I'm Julie Dewey, Orthofix's Chief IR and Communications Officer. Joining me on the call today are President and Chief Executive Officer, Massimo Calafiore; and Chief Financial Officer, Julie Andrews.
Before we get started, please note that our earnings release and the supplemental presentation accompanying this call are available on the Events and Presentations page of the Investors section of our corporate website at Orthofix.com. Also, this call is being broadcast live over the Internet to all interested parties, and an archived copy of this webcast will be available in the Investors section of our corporate website shortly after the conclusion of this call.
During this call, we'll be making forward-looking statements that involve risks and uncertainties. All statements other than those of historical facts are forward-looking statements. We do not undertake any obligation to revise or update such forward-looking statements. Factors that could cause actual results to differ materially are discussed in our most recent filings with the SEC and may be included in our future filings with the SEC.
In addition, on today's call, we will refer to various non-GAAP financial measures. Please refer to today's news release announcing our fourth quarter and full-year 2024 results for information regarding our non-GAAP results, including our reconciliations of these non-GAAP financial measures to our U.S. GAAP results. Additionally, all revenue percentage changes discussed will be on a constant currency year-over-year basis, and all results of operations that we will refer to will be on a non-GAAP as adjusted basis....
Read the full article on Seeking Alpha
For further details see:
Orthofix Medical Inc. (OFIX) Q4 2024 Earnings Call TranscriptNASDAQ: OFIX
OFIX Trading
-2.19% G/L:
$11.59 Last:
95,382 Volume:
$11.68 Open:



